BBIO

BridgeBio Pharma, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$73.15

Market Cap

$14.18B

Beta

1.18

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+126.26%

EPS Growth (YoY)-32.98%

Revenue CAGR 3Y+86.30%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.23%

Debt / Equity0.00

Interest Coverage-5.5x

No credit card required

Already have an account? Sign in to view the full analysis for BBIO.